News: Santhera Pharmaceuticals Holdings AG (SANN.S)

SANN.S on Swiss Exchange

26.95CHF
18 Dec 2009
Price Change (% chg)

CHF0.60 (+2.28%)
Prev Close
CHF26.35
Open
CHF26.30
Day's High
CHF26.95
Day's Low
CHF26.00
Volume
2,230
Avg. Vol
1,946
52-wk High
CHF52.40
52-wk Low
CHF23.50

view news for:
Select another date:

Tue, Dec 15 2009

WRAPUP 1-Addex drug flop deals blow to European biotech

* Elan, Transition hit by Alzheimer's drug setback (Adds analyst and company comment, industry detail)

Continue Reading

UPDATE 2-Addex stops development of lead drug

(Rewrites throughout with stopping development of lead drug)

UPDATE 1-Addex stops lead drug trial due to liver problems

* Addex trying to understand between liver problems and drug

Swiss stocks - Factors to watch on Dec 9

ZURICH, Dec 9 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Wednesday:

Swiss stocks - Factors to watch on Dec 8

ZURICH, Dec 8 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Tuesday:

UPDATE 1-Addex lead drug hits target in mid-stage study

* Addex says sees further development in ADX10059 study

UPDATE 3-Biovail profit dips but hunt for deals continues

* Shares off 1.3 percent at C$13.95 (Adds analyst and company quotes. In U.S. dollars)

UPDATE 3-Cytos anti-smoking vaccine flops; shares drop

(Rewrites, adds more comment, detail and updated shares)

Swiss stocks - Factors to watch on Oct 5

ZURICH, Oct 5 (Reuters) - Swiss shares were expected to edge higher on Monday as European markets were seen rebounding from a four-week closing low.

Swiss stocks - Factors to watch on Sept 4

ZURICH, Sept 4 (Reuters) - Swiss shares were seen opening slightly firmer after U.S. retail sales data boosted U.S. and Asian markets although there was caution ahead of a U.S. payrolls report.

Select another date:

Market Views

» More SANN.S Market Views

Press Releases

view news for: